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  Background: Cardiovascular disease (CVD) is one of the leading causes of death in the 
United States. A majority of the risk factors for cardiovascular disease are modifiable 
through drug therapy, diet, and exercise. Purpose: To determine if the student-run stress 
testing and exercise prescription program 1) resulted in subsequent lifestyle changes and 
in reduced CVD risk, 2) if the addition of pedometer-base exercise prescription in 
conjunction with weekly phone calls added to the student prescription would 
differentially reduce CVD risk, and 3) to determine if either of these interventions in 
middle-aged adults improves quality of life (QOL). Methods: Forty-two participants (21 
males, 21 females) were randomly assigned to one of two groups. Both groups received 
individualized exercise prescription interventions designed from a student-led 12-lead 
ECG exercise stress test, strength testing, body composition testing, and flexibility 
testing. One-half of the participants additionally received a pedometer-base program 
(PBP) that tracked daily step totals and included a weekly phone call. Results: In the 19 
participants who completed the 6 month study, overall HDL cholesterol increased (54.6 
to 62.8 mg/dL), LDL cholesterol decreased (121.5 to 104.2 mg/dL), and resting systolic 
blood pressure (SBP) decreased (126.7-120.2 mmHg) at an alpha level of < 0.05. Heart 
rate, body mass index, fasted blood glucose, and rating of perceived exertion did not 
significantly change from baseline values (p < 0.05). Subjects reported improvements in 
physical limitations, emotional well-being, and overall QOL was improved (p < 0.05). 
There were some differences between the two exercise interventions, but the small 
sample size who completed the testing limited the power of the analysis. Conclusion: 
Blood lipids, resting SBP, and QOL were significantly improved. The improvements in 
cardiac risk profiles, QOL, and participant evaluation forms suggest that positive lifestyle 
changes were made as a result of the intervention. 
  Keywords: individualized exercise prescription, pedometer-base program, cardiovascular 
disease, fasted blood glucose, body mass index, systolic blood pressure, rating of perceived 
exertion, high-density lipoprotein, low-density lipoprotein, electrocardiogram, quality of life.  
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CHAPTER I: INTRODUCTION 
 
 Cardiovascular diseases and strokes are estimated to annually cost the United 
States $503.2 billion, with coronary heart disease (CHD) attributing $177.1 billion. In 
2010, CHD was estimated to be prevalent in 785,000 Americans‟ lives (42). Although 
these figures are worrisome, research conducted between 1980 and 2000 reported a 44% 
decline in CHD mortality. The decrease in CHD mortality and risk factors is attributed 
mainly to improved medications and technology and to a smaller degree, lifestyle 
modifications (42).  
Cardiovascular disease (CVD) risk factors include: age, family history, smoking, 
inactivity, hypertension, dyslipidemia, obesity, and diabetes (including pre-diabetes, 
Type I and Type II Diabetes Mellitus) (40). Modifiable CVD risk factors include all of 
the above except age, family history, and Type 1 Diabetes Mellitus. All modifiable risk 
factors are alleviated by increasing physical activity and adjusting diet (10-14, 16-18, 31, 
40). Previous studies have shown that a single bout of aerobic exercise can decrease 
blood pressure in moderately hypertensive individuals, help normalize blood sugars and 
decrease triglycerides for several hours (9, 10, 39). Additionally, chronic physical activity 
has a positive effect on obesity, dyslipidemia, hypertension and normalizing blood 
glucose. Thus, lifestyle may possibly have a major impact on reducing CVD and 
improving quality of life. 
There is general agreement in the literature about the positive health benefits and 
improved physiological parameters, such as improved blood lipid profiles and insulin 
sensitivity, which result from regular exercise. However, the optimal exercise frequency, 
intensity, mode, and duration for specific populations remain controversial (13-22, 27-
2 
 
33). Aerobic capacities vary across individuals; therefore, individually designed exercise 
programs specific to the physical ability of an individual will yield more compliance, be 
safer, and return greater health benefits. An exercise stress test is the most common 
method to evaluate CVD and is often used to prescribe an exercise program. However, it 
is unknown if a pedometer-base exercise program, developed from the results of an 
exercise stress test, will effectively reduce risk factors or symptoms of CVD.  
A variety of pedometer-base interventions have been reported in the literature, 
and most have successfully increased physical activity or steps/day (1-8). Also, a few of 
the pedometer-based studies have shown decreased blood pressure, lowered body mass 
index (BMI), improved lipid profiles, and increased insulin sensitivity (1-7). In a recent 
systematic review of 18 observational pedometer studies and 8 randomized controlled 
trials, Bravata and colleagues reported a pedometer program associated health benefits in 
many adult populations, including but not limited to, sedentary women, overweight 
adults, arthritic adults, and diabetic adults (39). Tudor-Locke and colleagues affirmed the 
convergent and construct validity of pedometers as a physical activity measuring tool in 
two systematic reviews of 25 and 29 published articles, respectively. Tudor-Locke and 
colleagues also found a significant relationship between pedometer-determined physical 
activity and the following improved health-related outcomes: blood pressure, blood 
glucose, and lipid profiles (35, 36).  
Pedometer-base interventions have had the most success as a behavior 
modification tool when subjects were not covertly monitored, when realistic goals were 
set, and when a daily step log was kept (1-8). Therefore, the attention of pedometer-base 
studies should focus on the subjects‟ quality of life (QOL) before and after the program 
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to establish a greater mental as well as physical understanding of structured physical 
activity.    
 To date, this author is unaware of any studies comparing an individualized 
exercise prescription (IEP) with a pedometer-base program (PBP), on QOL in middle-
aged adults. QOL changes have been measured across a variety of regular exercise 
interventions and have shown significant improvement when physical fitness also 
improves (23-26). However, there is limited evidence that a relationship exists between 
improved QOL from increased physical fitness and reduced CVD risk factors. Thus, the 
aim of the present study is to determine if an individual exercise prescription (IEP) 
designed from an exercise stress test, or exercise prescription in conjunction with a 
pedometer-base program (PBP) for 6 months, effectively reduces CVD risk factors and 
improves quality of life. It is hypothesized, according to the majority of previous 
research, that the two exercise programs, IEP and PBP, will both reduce CVD risk factors 
and improve QOL, with the greatest benefits expected when both the IEP and PBP are 
implemented together. 
 
Statement of Problem: 
In the Health and Human Performance Lab, we have offered free stress tests with fitness 
testing to over 300 Missoula community members including 150 faculty and staff from 
the University of Montana. Following the stress, flexibility, strength, and body 
composition tests, students have met with the participants and designed individualized 
exercise prescriptions and behavior change programs to help each individual lower their 
risk for CVD. While this is an excellent learning environment for undergraduate students, 
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it is unknown if the program is having a positive benefit for participants and if there are 
simple additions, such as the use of a pedometer, that might make the program more 
successful. 
Thus, the objectives of the present study are three fold: 1) To determine if exercise and 
the subsequent lifestyle change following the exercise stress and other testing is helping 
individuals in changing their behaviors and resulting in reduced CVD risk, 2) If the 
addition of pedometer-base exercise prescription in conjunction with weekly phone calls 
added to the student prescription will differentially reduce cardiovascular risk, and 3) To 
determine if either of these interventions in middle-aged adults improves their quality of 
life. 
 
Research Hypothesis: 
The two exercise programs, exercise prescription and pedometer-base, will improve 
cardiovascular risk factors and quality of life, with the greatest improvements expected 
when both exercise prescription and pedometer-base programs are implemented. 
 
Significance of Study: 
This study combines laboratory measures with field data collection to ultimately promote 
health to middle-aged adults in the Missoula, Montana community. This study is 
generated from a unique program, using student service-learning to provide stress testing 
and individualized behavior change patterns. The data collection from past years has yet 
to be examined, thus the effectiveness of the program on behavior change is not yet 
known. Therefore, this study will statistically evaluate 6 month outcomes of the current 
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program and also evaluate if the addition of a pedometer and step program will further 
enhance CVD risk reduction and quality of life. 
 
Rationale of Study: 
The present study combines methods from both qualitative and quantitative data in a non-
invasive design that will evaluate a student service-learning program designed to both 
enhance student learning while providing a service to help community members reduce 
CVD risk factors. The service learning program has been provided by the Health and 
Human Performance Department for several years. This study may also have a positive 
effect on community members in Missoula, Montana by helping to reduce CVD risk 
factors in a portion of the population. Lowering CVD risk is important as coronary artery 
disease (CAD) is the leading cause of mortality among Missoula residents (44). The aim 
of this study is to reduce cardiovascular diseases, such as CAD, by promoting an increase 
in physical activity and encouraging the participants to change their unhealthy lifestyle 
behaviors, such as poor nutrition. Student feedback suggests that the current program is a 
valuable learning tool, which alone, provides strong rationale for the program. 
Furthermore, this study is justified if even one subject improves health, quality of life, or 
behavior change. Findings from the current study have the opportunity to provide future 
direction for the program. 
  
Limitations and delimitations: 
1. The participants were all volunteers, recruited mainly from the faculty and staff 
population at the University of Montana via email, recruitment flyers and 
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brochures, public service announcements, and by “word of mouth.” Therefore, 
this is not a random sample and results may not be generalizable.  
2. The sample size is relatively small and mostly middle-aged Caucasians, which 
also effects population generalizability. 
3. The inclusion criterion for participants in the pedometer-base group requires that 
the participants be ambulatory, thus individuals with disabilities were not 
evaluated. 
4. The participants had to be willing to self-monitor and self-report their steps per 
day. 
5. Participant retention is voluntarily based.  
6. Different researchers will be collecting the data for pre- and post- measurements, 
so measurement consistency is disrupted.  
7. The participants were not expected to keep a dietary journal, so changes in dietary 
intake were not assessed; thus, potential changes in CVD risk factors such as 
blood pressure, lipids, or body composition, cannot be attributed to exercise 
alone. 
8. Medications are being used by many of the participants and could affect the 
exercise response. 
9. The impact of the seasons, fall and winter, could influence the participants‟ 
willingness to walk outside. 
10. The study is relatively short and the long-term effect of the intervention is 
unknown. 
11. The number of steps reported by the pedometer each day does not reflect intensity 
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12. Overestimation and underestimation errors may occur due to improperly waist-
mounted pedometers, or the physical activity mode may amplify/underestimate 
actual steps. 
13. The study population was delimited to individuals willing to participate in a 
service-learning project without regard to the number of risk factors at baseline.  
Thus the population includes both healthy and at-risk individuals. 
Definition of Terms: 
 Accelerometer: a small instrument worn around the waist-line, wrist, or ankle 
that measures proper acceleration per time frame and can be used to determine 
energy expenditure.  
 Aerobic capacity: the maximal amount of oxygen one can consume and utilize 
per minute during exercise. 
 Body composition: for this study, body composition is determined as fat mass or 
% body fat (%BF) and fat-free mass components of the human body. 
 Body mass index (BMI): a standard measurement that uses weight in kilograms 
divided by height in meters squared to estimate over-weightiness and risk for 
some chronic diseases. 
 Construct validity: the extent to which measurements can be shown to 
correspond with measures of theoretically related parameters (36). 
 Convergent validity: the extent to which an instrument‟s output correlates with 
measurements from similar instruments hypothesized to measure the same 
exposure of interest (36). 
 Covertly Monitoring: a study design that prohibits its subjects from being aware 
that their activity levels are getting evaluated. 
 Duration/Time of exercise: how long each bout of exercise lasts, usually 
measured in minutes. 
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 Dyslipidemia as a risk factor for cardiovascular disease: this study considered 
a low-density lipoprotein cholesterol >130 mg dL
-1
 or a high-density lipoprotein 
cholesterol <40 mg dL
-1
, or if one was on lipid-lowering medication; also, if total 
serum cholesterol was >200 mg dL
-1
 a risk for CVD was decided (41). 
 Exercise Stress Test: a progressive exercise test to evaluate cardiovascular health 
of an individual.  
 Exercise: a subset of physical activity that is planned, organized, repetitive, and 
provides meaning in the sense that improvement or maintenance of physical 
fitness is the goal (34). 
 Family history as a risk factor for cardiovascular disease: Family history is 
considered to be a risk factor for CVD when first degree relatives have had 
myocardial infarction, coronary revascularization, or sudden death before 55 
years of age in male first-degree relative, or before 65 years of age in first-degree 
relative (41). 
 Frequency of exercise: how often exercise is performed, usually number of days 
per week. 
 Hypertension as a risk factor for cardiovascular disease: hypertension is a risk 
factor for CVD when a person‟s systolic blood pressure is >140 mm Hg and/or 
diastolic blood pressure >90 mm Hg on measurements of at least two separate 
occasions; those on anti-hypertensive medication are also considered at risk for 
CVD (41). 
 Individualized Exercise Prescription (IEP): a combination of aerobic training, 
resistance training, balance, and flexibility exercises engineered according to an 
individual‟s weaknesses, goals, health screening, health measures, and an exercise 
stress-test. 
 Inactivity (sedentary lifestyle) as a risk factor for cardiovascular disease: 
inactivity is considered a risk factor for CVD when a lifestyle does not include at 
least 30 minutes of moderate intensity physical activity on at least three days of 
the week for at least three months (41). 
9 
 
 Insulin sensitivity: refers to the muscle cell‟s insensitivity to the hormone, 
insulin, resulting in reduced or no glucose uptake from the blood to muscles and 
high blood glucose.  
 Intensity of exercise: the amount of energy expenditure that it takes to perform a 
bout of exercise, usually measured as light (1-3 METs), moderate (3-6 METs), or 
vigorous (>6 METs). 
 Metabolic equivalent (MET): a physiological unit expressing the energy cost of 
physical activities; 1 MET is defined as the amount of energy it takes to quietly 
rest in a lying or seated position, and it is conventionally considered to equal 3.5 
mL O2 kg
-1
min
-1
 or about 1 kcal kg
-1
 min
-1
. 
 Mode/Type of exercise: the way the exercise is performed, such as walking, 
jogging, biking, swimming, weight-lifting etc.  
 Myocardial Ischemia: decreased oxygen supply to cardiac muscle due to lack of 
coronary blood flow; recognized on an electrocardiogram (ECG) as ST segment 
depression >2 mm and commonly manifested as angina pectoris (41). 
 Obesity as a risk factor for cardiovascular disease: a body mass index >30 
kg m
2
 or waist girth >102 cm for men and >88 cm for women. 
 Pedometer-base program (PBP): a system of exercise prescription that uses a 
pedometer, which is a small, electronic, step counting device. 
 Physical activity: any bodily movement produced by skeletal muscles and results 
in energy expenditure beyond resting expenditure (34). 
 Physical fitness: involves a combination of cardiorespiratory fitness, strength, 
flexibility, coordination, and balance ability that people exhibit during the 
ordinary and extraordinary demands of life 
 Pre-diabetes as a risk factor for cardiovascular disease: also called impaired 
fasting glucose (IFG) is established by an 8-hour fasting blood glucose >100 
mg dL
-1
 and < 126 mg dL
-1
 confirmed by measurements on at least two separate 
occasions (41). 
 Quality of Life (QOL): one‟s personal outlook or opinion about life related to 
health 
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 Randomized controlled trial: a process in research that allows each participant 
or subject to have an equal chance of being in either the control group, IEP, or the 
experimental group, IEP + PBP. 
 Reliability: a measure of the extent to which an instrument, such as a pedometer, 
is free of measurement error. 
 Smoking as a risk factor for cardiovascular disease: smoking tobacco 
cigarettes is considered to be a risk for CVD when a person is either a current 
cigarette smoker or has quit within the previous six months; also if a person is 
exposed to environmental tobacco smoke (41). 
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CHAPTER II: REVIEW OF LITERATURE 
 
Heart Disease at the Forefront 
 
Heart disease research dates back to the 1950s. Morris and Crawford, in the 
London Bus Drivers and Conductors study, analyzed occupational health data from 
which they reported that males with higher physical demanding occupations had fewer 
histories of heart disease (43). Much research to date has focused on the etiology of heart 
disease and the role of physical activity in heart disease prevention. Diseases in any form, 
especially heart disease with its high mortality rate, inhibit activities of daily living and 
diminish quality of life. This review of current literature aims to examine the literature 
related to how physical activity mediates physiological parameters, such as blood 
pressure, insulin sensitivity, blood lipid profiles, or signs of ischemia, and improves 
quality of life. A second portion of this review evaluates the effectiveness of exercise 
interventions, such as pedometer-base programs.    
 Coronary heart disease (CHD) is a form of cardiovascular disease (CVD) that 
occurs when plaque accumulates in the arteries, interrupting blood supply to the heart. 
The plaque narrows the arteries over time in a process called atherosclerosis. CHD is the 
most common form of heart disease, and is the leading cause of death in the United 
States. It is estimated that in 2010, the cost of CHD in the United States will be 177.1 
billion dollars (42). However, as a result of medications, dietary interventions and 
increased physical activity, researchers have reported a declining trend in CHD mortality 
since 1980 (42).   
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The CVD risk factors include: age, family history, cigarette smoking, inactivity, 
hypertension, obesity, high cholesterol, pre-diabetes and diabetes (41). Lifestyle 
modifications that include habitual physical activity (PA) have been shown to reduce 
CVD risk factors and the incidence of CAD (30). Examples of simple PA lifestyle 
modifications may include: using the stairs instead of the elevator, walking or riding a 
bike short distances rather than driving, seeking further parking spaces at the store, or the 
development and maintenance of a physical activity program. Physical activity 
interventions using purposeful activity several times a day have been shown to be 
effective and possible, especially when compared to more difficult lifestyle modifications 
such as  smoking cessation, a 25% caloric intake reduction, or beginning a formal 
exercise program (14, 15).  
Exercise is a form of physical activity that is planned, structured, repetitive, and 
involves goals aimed at health enhancement. Physical exercise and physical activity have 
both been shown to be effective behaviors to improve health when individuals meet 
frequency, intensity and duration guidelines. However, because physical activity is 
defined as any bodily movement produced by skeletal muscles above resting expenditure, 
it is necessary to clearly define the required intensity (34). The American College of 
Sports Medicine (ACSM) and the American Heart Association (AHA) recommend 30 
minutes of moderate physical activity on five days of the week or to accumulate 150 
minutes per week in at least ten minute bouts of sustained physical activity. These 
recommendations have shown to promote and maintain health and significantly reduce 
the risk for CAD (26, 30, 40). Exercise recommendations are slightly changing to fit the 
needs of different populations, but the current ACSM and AHA literature has not 
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revealed significant changes to the recommendations. Exercise, especially during ages 45 
and older, has the greatest impact on reducing the risk for heart disease (27). 
 
The Physiological Parameters 
 
Blood Pressure 
There is strong evidence in the literature that exercise is an effective treatment for 
hypertension. Fagard and Cornelissen (2007) constructed a comprehensive meta-analysis 
of 72 randomized controlled trials involving dynamic aerobic endurance training and its 
effect on systolic (SBP) and diastolic blood pressure (DBP). The studies of both 
normotensive and hypertensive groups resulted in significant decreases in resting blood 
pressures (SBP/DBP, normotensive reduction = 1.9/1.6 mmHg and hypertensive 
reduction of 6.9/4.9 mmHg, p<0.0001).  Other similar data has been reported in a review 
of 44 randomized controlled trials, which found a 2.6/1.8 mmHg decrease in 
normotensive subjects and a 7.4/5.8 mmHg decrease in hypertensive subjects (38, 40). 
These decreases in blood pressure from aerobic exercise training are attributed to a 
reduction in systemic vascular resistance due to the favorable involvement of the 
sympathetic nervous system and the renin-angiotensin system (38).  
Ambulatory blood pressure, a technique that compares blood pressure during 
activities of daily living, was found to stay lowered 24 hours after an aerobic exercise 
session of 40 minutes on a cycle ergometer at 60% of their heart-rate reserve in 50 
hypertensive patients (9). Therefore, even a single bout of exercise has been shown to 
lower blood pressure for hours following exercise. 
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Exercise interventions lasting 6 months have also shown to have significant 
effects on blood pressure. Blumenthal and colleagues (2000) found a 4 mmHg SBP and 
DBP reduction after an aerobic exercise intervention for 6 months in 133 sedentary and 
overweight men and women (10). Lifestyle interventions, which included increased 
physical activity, educational information, and dietary changes for 6 months were shown 
to decrease blood pressure and overall CHD risk in 810 relatively healthy adults (12). 
Another 6 month aerobic exercise and weight loss program compared 9 sedentary, 
hypertensive obese men to 8 normotensive, sedentary lean men. With just 3-4 days of 
exercise per week, blood pressures in both hypertensive and normotensive men were 
decreased. Greater blood pressure reductions were correlated with greater weight-loss 
and significant improvements in cardiovascular fitness and improved glucose and 
lipoprotein metabolism (11). 
 
Blood Glucose 
Diabetes and insulin insensitivity, which are CVD risk factors, are an increasing 
concern, but the literature has revealed increased insulin sensitivity and diabetes 
maintenance with exercise implementation. Insulin sensitivity refers to the body‟s ability 
to metabolize excess glucose via insulin, a hormone which is released by -cells located 
in the pancreas. Rhéaume et al. (2002) studied 10 hypertensive subjects and compared 
them to 10 normotensive subjects. After a 30 minute cycle ergometer ride at 50% of 
VO2peak, an intravenous glucose tolerance test determined that the single bout of exercise 
significantly increased insulin sensitivity in hypertensive adults (15). It was also 
determined by Slentz and colleagues (2009) that an inactive control group experienced a 
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significant increase in fasting glucose in a study involving 387 sedentary, overweight 
adults randomly assigned to three different training groups and one control group (13). 
The physiological mechanism for increased insulin sensitivity due to increased physical 
activity is still unknown, but it is suggested that exercise improves -cell functioning 
(13).    
Other researchers have looked at larger populations and the effects of lifestyle 
modifications.  They have found evidence linking physical activity to a lower incidence 
of diabetes. A randomly controlled trial of 3,234 non-diabetic persons with elevated 
fasting and post-load plasma glucose concentrations were either assigned to a placebo or 
a lifestyle-modification group with the goals of at least a 7% weight loss and at least 150 
minutes of physical activity per week. Both interventions decreased cases of diabetes, but 
the lifestyle-modification intervention was more effective (14). Lindström and colleagues 
(2006) did a randomly controlled trial that involved a 7-year follow-up on 522 adults at 
high risk for type 2 diabetes; it was concluded that those in the active lifestyle 
intervention group resulted in sustained lifestyle interventions and reduced diabetes 
incidence (16).  
 
Obesity 
Diabetes researchers have consistently found a connection between increased type 
2 diabetes mellitus and obesity. Obesity is a rising epidemic, and the World Health 
Organization estimates that globally over 700 million people will be obese by 2015 (42). 
Although many overweight people may never become obese, the CVD risk factors, 
including obesity, are elevated in overweight individuals. Lefever et al. (2009) performed 
a 6 month study on calorie restriction and calorie restriction with exercise, which 
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involved 36 overweight subjects randomized into four groups. A greater reduction in 10-
year CVD risk was observed in the groups that involved calorie restriction with exercise 
and intense calorie restriction to rapidly achieve 15% of weight loss (17).  
 The literature on obesity reveals the importance of physical activity in populations 
more susceptible to obesity. Thompson and colleagues (2004) used a 7 day pedometer 
intervention with 80 middle-aged women and reported that women with more recorded 
steps had a lower percent body fat, waist circumference, hip circumference, and waist-to-
hip-ratio (19). A prospective cohort study of 38,987 women showed that 30 minutes of 
daily activity effectively reduced BMI.  The same study stressed the importance to be 
lean and physically active in order to reduce CVD risk factors (20). Although obesity has 
been attributed to the over consumption of food and genetics, another key component is a 
lack of physical activity.  
 Larson-Meyer and colleagues (2010) used a similar study design as Lefever et al. 
(2009), except the focus was on fat mass and visceral abdominal mass reduction. The 
overweight participants in the calorie restriction and exercise groups lost more fat mass. 
Further, it was observed that the groups with exercise included into the intervention 
decreased DBP, decreased low-density lipoprotein (LDL) levels, and improved insulin 
sensitivity (18). Obesity research suggests that overweight, middle-aged men and women 
can decrease body and fat mass, improve insulin sensitivity, and improve lipids and 
lipoproteins with increased physical activity (18, 21).   
 
Blood Lipid Profiles 
 Commonly used language refers to cholesterols as “bad” lipoproteins, (LDL), and 
“good” high-density lipoproteins (HDL). Triglycerides are commonly measured in 
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conjunction with the cholesterols. Triglycerides are derived from glycerol and fatty acids 
formed together in an ester bond. Individuals who are sedentary and/or overweight are 
likely to have a greater prevalence of LDL and triglycerides and a lower prevalence of 
HDL. Moderate-intensity exercise has been shown to sustain lowered LDL and 
triglyceride levels for up to 15 days post exercise training, and 30 minutes per day of 
vigorous exercise can increase plasma HDL cholesterol (23). Leon and colleagues (2000) 
found that an acute bout of aerobic exercise can significantly reduce plasma triglycerides 
for 24 to 48 hours, consistent with previous research (22).  
 
Myocardial Ischemia and Heart Rate Changes 
Myocardial ischemia and heart rate changes are other variables that may be 
considered when evaluating CVD. Myocardial ischemia, which is low oxygen supply to 
cardiac muscle resulting from the lack of coronary blood flow, can result in reduced heart 
function, congestive heart failure, and, if sustained, a myocardial infarction. A favorable 
effect on blood flow was reported in 7 patients with documented coronary heart disease 
when exercise training 4 days per week for an hour each day was implemented.  Subjects 
also had lowered resting heart rates (32). It has been reported that lower resting heart 
rates, normal sinus rhythms, and a heart rate recovery of greater than 12 beats per minute 
during the first minute of recovery suggests a healthy prognosis (41). Exercise has been 
shown to benefit post-infarction patients as well. Lee et al. (2008) studied 39 post-
infarction patients. Twenty of the patients were prescribed exercise 3 days per week for 3 
months; perfusion reserve was significantly improved in both the infarcted and remote 
myocardium compared to the non-exercise group (30). 
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 Long-term studies on exercise as a preventative tool against myocardial ischemia 
have been conducted. A prospective cohort study of 11,914 Danes, all older than 20 
without pre-existing IHD (ischemic heart disease), were followed for 20 years and found 
to have low hazard ratios of both IHD and all-cause mortality when greater than 4 hours 
of light physical activity per week were reported (31). Also, Pigozzi et al. (2005) 
followed 88 male subjects, all aged above 66 years, for 4 years, and determined that 
exercise can reduce the cardiovascular risk factors and decrease the overall incidence of 
heart disease, such as positive ST segment depression during the initial 12-lead ECG 
testing (33). Although research suggests that physical activity improves oxygen supply to 
the myocardium, which improves the ability to perform activities of daily living (ADLs) 
and decrease depression, extreme caution must be taken for exercise prescription and 
doctor referral is necessary if myocardial ischemia is observed (25, 30-33). 
 
Physical Activity and Quality of Life 
 
Diseases that interrupt activities of daily living (ADL) have an impact on quality 
of life. The literature supports the popular notion that regular physical activity aids in the 
prevention of cardiovascular diseases (11, 12, 17, 27-29, 33, 34, 39-43). Therefore, the 
connection between improved QOL and increased physical activity through an exercise 
program has received interest. Authors of a study that involved 175,850 adults reported 
that participants who met the recommended levels of physical activity were associated 
with better overall health-related quality of life and perceived health status. Häkkinen and 
colleagues (2010) used the RAND SF-36 in a cross-sectional study on 727 men and 
determined that health-related physical fitness promotes health-related quality of life 
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(26).  A randomized controlled trial on 430 sedentary, postmenopausal women with 
elevated SBP suggested that 6 months of higher doses of exercise were associated with 
improvements in mental and physical aspects of QOL (23). The physical benefits from 
exercise programs, such as simply walking 30 minutes per day, can lengthen the human 
lifespan, but dually significant, is the importance of improved happiness from exercise 
during a longer life.   
 
Pedometer Base Physical Activity Programs 
 
The pedometer is a validated instrument to measure steps, and it encourages 
increased physical activity effecting health and health-related quality of life (35, 36). 
Pedometers allow ambulatory populations to track their steps, which influences 
motivation through goal-setting.  Clemes et al. (2009) observed better compliance and 
more accumulated steps in the subjects treated with unsealed pedometers and a daily 
step-recording log (1). The actual subject steps taken per day increased in a study by 
Basset and colleagues resulting in self-achievement and increased energy expenditure (3). 
The combination of having step goals and immediate feedback was effective in 
increasing physical activity levels in 26 overweight and obese women (4). Zoellner et al. 
(2010) reported that steps per day significantly increased in 83 African Americans during 
a pedometer-base program, and when the importance of setting realistic and personalized 
weekly goals was prioritized (7). The current literature supports the health promotion 
benefit from pedometers; however, reductions in CVD risk factors due to pedometer-base 
programs need continued evaluation. 
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Walking briskly on level ground for 30 minutes, which is equivalent to 
moderately-intense exercise, or accumulating 30 minutes daily, in at least 10 minute 
segments, can promote health (41). Moderately-intense exercise is recognized as 3-6 
METs or 50-60% of maximum oxygen uptake. The Honolulu Heart Program began 
monitoring 8006 men of Japanese ancestry in 1965. From 1991 to 1993, a sample of 2678 
men in the study, then aged 71-93, was examined for distance walked. The CHD risk in 
these elderly men was reduced relative to distance walked (28). Nemoto and colleagues 
(2007) used a randomly controlled trial to monitor 60 men and 186 women with an 
accelerometer and a pedometer.  They reported that the group with more steps performed 
at a higher intensity and improved peak oxygen uptake and reduced blood pressures (SBP 
dropped 9 mmHg and DBP dropped 5 mmHg) (6). In summary, the ability of pedometer-
base programs to improve health outcomes from lengthened walking time and distance 
are well documented (1-8, 35, 36, 39). 
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CHAPTER III: METHODOLOGY 
 
Research Setting & Design 
This study was approved by the Institutional Review Board at the University of Montana 
and informed consent was obtained from all participants before any testing proceeded (A-
2, pp50-53). The participants were recruited by informational brochures, “word of 
mouth,” and via email. Initial participant screening included information about the 
exercise stress testing program, preparation for the exercise stress test, a health screening 
questionnaire, and directions to the lab. All the initial and final measurements were 
obtained in a controlled environment at the University of Montana. Participants were 
required to meet on 3 separate occasions: first, for the exercise stress testing, second, for 
anthropometric, hydrostatic weighing, strength, and flexibility measurements, and third, 
for an exercise program overview and concise instructions for their new exercise 
program. If requested, students often met with clients for one or more additional meetings 
to help clients learn how to perform exercises or to refine the individual programs. The 
first two meetings occurred from 6:00 am to 8:00 am on Monday, Wednesday, or Friday 
in McGill Hall labs (rooms 131 & 116), on the University of Montana Campus. The final 
meeting(s) occurred at a public location convenient to each participant. This study was 
designed to combine both lab and field feedback for descriptive analysis. 
 
Participants 
The participants included 42 adults, mostly aged 55 and older, and they were recruited 
through emails and a „stress-test brochure‟ (A-4, pp73). They voluntarily enrolled in an 
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exercise testing program at the University of Montana. Each participant went through a 
pre-screening process to determine the number of health risk factors (A-1, pp48-49). 
Participants aged 55 and older were encouraged to enroll, but there were no biases toward 
age (younger participants were allowed if they requested the testing), race, religion, 
gender, economical status, or current health status.  
 
Procedures 
Sample Selection: 
From the forty-two participants recruited, half were randomly assigned by a 
computerized number generator to one of two groups. The experimental group received 
individualized exercise prescription (IEP) and pedometer-base program (PBP) 
interventions. The control group received the IEP intervention only. After the exercise 
testing and data collection, the experimental group was assigned an unsupervised, well-
rounded exercise program that included strength training, aerobic activity, a dietary 
guide, a free pedometer, a daily step-log, and a weekly phone call for three to four 
months. The control group was provided with just the unsupervised, well-rounded 
exercise program that included strength training, aerobic activity, a dietary guide, and a 
monthly phone call for six months. Each group was administered a validated quality of 
life survey (RAND SF-36 QOL Survey) prior to both exercise stress tests. The initial 
tests were in October-November, 2010, and final tests were conducted in March-April, 
2011. 
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Measurements: 
On the day of the exercise stress test, participants arrived to the lab fasted for 8-12 hours 
before all measurements began. The dependent variables included: weight, height, waist 
to hip ratio, fasted blood glucose, total cholesterol, high-density lipoprotein, low-density 
lipoprotein, triglycerides, blood pressure, heart rate, body mass index, percent body fat, 
rating of perceived exertion, ischemia based on 3 main factors: T-wave inversion, ST 
segment depression, and ST segment elevation, bench press, leg press, handgrip strength, 
flexibility (sit and reach), and quality of life. The dependent variables were gathered 
twice for pre- and post-measurements. The independent variables were the exercise 
prescription programs (individualized exercise prescription or pedometer-base program in 
conjunction with the individualized exercise prescription). The pre- measurements and 6 
month post- measurements were compared for between-group interactions and overall 
main effects.  
Instrumentation: 
The participants‟ weights were recorded in kilograms and measured with a digital scale 
with load cells, and their heights were determined with a standard meter ruler. BMI was 
then calculated by dividing the weight in kilograms by the height in meters squared. 
Blood glucose (mg∙dL-1) was measured following an overnight fast with the One-Touch® 
Ultra-Mini Blood Glucose Meter. The lipid profile (mg∙dL-1) and triglyceride (mg∙dL-1) 
measurements were collected with the Cardio Chek® P.A. requiring a 25uL of blood 
from a finger prick. Exercise stress tests were performed on a calibrated treadmill using 
the Bruce Ramp treadmill protocol (A-5, pp68). A 12-lead electrocardiograph (ECG), 
blood pressure (mmHg), rating of perceived exertion (RPE) based on the 6-20 BORG 
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scale, and angina (0-4 scale) and dyspnea (0-4 scale) were recorded at the end of each 
stage.  
The Bruce Ramp treadmill protocol consisted of a warm-up stage (53.2 meters•min
-1
, 0% 
grade) and up to four progressive exercise stages, and a cool-down stage (53.2 
meters•min
-1
, 0% grade). Tests were terminated based on the ACSM Guidelines (A-6, 
pp74) for test termination.  In general, tests were terminated at 80% of estimated maximal 
heart rate or signs of ischemia.  Low risk participants were allowed to continue to higher 
intensities if they desired and had no indications to stop the test.  
Blood pressures were obtained through a standard sphygmomanometer and stethoscope 
to hear the Korotkoff sounds. The 12-lead ECG and heart rate was monitored 
continuously using the Cardio Card® Computer Software.   
Hydrostatic weighing was measured with the ElectroTech® strain gauge load cell 
underwater scale hardware and software.  The scale was calibrated prior to each test.  
Calculation of body density used estimated residual volume and 0.1 L gastrointestinal 
gas.  Body composition (% fat and % lean body mass) was calculated using gender and 
age specific formulas of Lehman.  
Daily pedometer step totals (W4L classic Walk4Life®) were self recorded by 
participants. Quality of life was evaluated using the RAND SF-36 health survey, which 
uses a Likert scale to measure 8 different dimensions: general health, physical 
functioning, role limitation physical, role limitation emotional, vitality, mental health, 
social functioning, and bodily pain (26) (A-9, pp77-78).    
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Statistical Analysis 
All data were analyzed with Microsoft Excel® and SPSS® computer software. 
Descriptive data were expressed as mean ± SD. A repeated measures, mixed model (time 
by treatment), ANOVA was used to examine pre- and post-study between group 
differences in BMI, FBG, total cholesterol, HDL, LDL, resting SBP, resting HR, or HR 
and RPE at stage 2 of the Bruce Ramp treadmill protocol. The 8 dimensions and total 
quality of life scores were compared with a paired samples t-test to determine the main 
effects. A repeated measures, mixed model (time by treatment) ANOVA then compared 
interaction effects on quality of life between the groups. A Bonferroni confidence interval 
adjustment was used on estimated marginal means for between-group interactions. Any 
comparison that yielded a Cook‟s D score >1 was considered an influential case and was 
appropriately accounted for. Comparisons were considered statistically significant at an 
alpha level of 0.05 for both the analysis of variance and t-test statistics. 
The participants in the current study were encouraged to record their steps daily, but the 
logs included a footnote stating that although it is important to track daily steps, it is also 
understandable when a few days are missed (A-8, pp76). The steps recorded in the 
pedometer group were used as anecdotal evidence for physical activity. Thus, actual step 
values were not statistically analyzed. 
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CHAPTER IV: RESULTS 
 
Participant Retention & Descriptive Statistics 
Of the 42 participants from the initial testing, 25 (13 males, 12 females) followed up with 
the final testing. Due to voluntary dropout and incomplete data, pre- and post-data for 19 
(11 males, 8 females) participants were statistically analyzed and reported on. The 
average age of the 19 participants who completed the study was 52.4 ±11.6 years (28 
to70 years). The overall pre- and post- descriptive statistics are shown in table 1.  
  
Table 1: Descriptive statistics (PRE- and POST- intervention) of all measured (dependent) variables for the 
whole group (N=19). Data are represented as the Mean ± Standard Deviation (STDEV). 
 
Nine of the initial 21 participants (42.9%) in the IEP group accounted for 21.4% of the 
total participant retention, and 16 of the 21 initial participants (76.2%) with both the IEP 
and PBP accounted for 38.1% of the total participant retention. Thus, the total participant 
retention for the program was 25 out of the initial 42 participants (59.5%), with greater 
compliance observed in the group that received a weekly phone call and participated in 
the pedometer-base program. Six of the returning participants had missing data or 
unanalyzed data because their final testing was completed after the cut-off date for 
inclusion. 
DEPENDENT VARIABLES PRE POST
N Mean STDEV N Mean STDEV
Age 19 52.4 11.6 19 52.4 11.6
Body Mass Index 19 23.9 3.6 19 24.1 3.6
Fasted Blood Glucose 19 95.8 9.9 19 99.4 10.8
Total Cholesterol 19 197.6 50.9 19 192.8 49.2
High-Density Lipoprotein 19 54.6 15.5 19 62.8 18.3
Low-Density Lipoprotein 19 121.5 42.3 19 104.2 40.8
Resting Systolic Blood Pressure 19 126.7 9.7 19 120.2 5.5
Resting Heart Rate 19 68.8 16.2 19 68.2 10.8
Heart Rate @ Stage 2 19 125.8 23.6 19 123.2 18.5
Rating of Perceived Exertion @ Stage 2 19 11.6 1.8 19 11.4 2.4
Overall Quality of Life 18 640.4 134.1 18 676.6 90.8
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Changes in CVD Risk Factors 
In the following sections, results of the intervention on each risk factor are shown. The 
overall change for all participants, the change for each group, and the interaction between 
groups are analyzed. The small sample size supports evaluation for only the main effect; 
however, for the purpose of this thesis, groups and interaction results are shown. The full 
statistical data can be found in the appendix (A-3, pp54-72). 
Body Mass Index (BMI) 
There was no significant overall change observed between the participants‟ BMI values 
for the pre- and post- interventions, as demonstrated by figure 1 (Pre=23.9 ±3.6, 
Post=24.1 ±3.6 kg/m
2
, p=0.417). Also, there were no within-group changes, as shown in 
table 2 (p=0.585). 
Figure 1: Body mass index (kg/m
2
) for each intervention and overall group comparison versus Pre- (Time 
1) and 6 month (Time 2 or Post-) measurements. Interventions for all figures: IEP = individualized exercise 
prescription; PBP = pedometer-base program + IEP. Standard error bars are on the overall scores only. 
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 Table 2: The Time row demonstrates the overall BMI main effect. Time * Treatment shows if there is 
significant BMI interaction between the groups (IEP or PBP +IEP).     
 
Fasted Blood Glucose (FBG) 
There was no significant overall change observed between the participants‟ FBG values 
for the pre- and post- interventions, as demonstrated by figure 2 (Pre=95.8 
±9.9,Post=99.4 ±10.8 mg/dL, p=0.264). Also, there were no within-group changes, as 
shown in table 3 (p=0.814). 
 
Figure 2: Fasted blood glucose (mg/dL) for each intervention and overall group comparison versus Pre- 
(Time 1) and 6 month (Time 2 or Post-) measurements. Interventions for all figures: IEP = individualized 
exercise prescription; PBP = pedometer-base program + IEP. Standard error bars are on the overall scores 
exclusively. 
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Table 3: The Time row demonstrates the overall FBG main effect. Time * Treatment shows if there is 
significant FBG interaction between groups (IEP or PBP +IEP). 
 
Total Cholesterol (TotChol) 
Total cholesterol did not change overall, as shown by figure 3 (Pre=197.6 ±50.9, 
Post=192.8 ±49.2 mg/dL, p=0.287). However there was a between-group interaction 
(p=0.047), with the IEP group improving 20.4 mg/dL and the IEP+PBP worsened 6.6 
mg/dL. 
 
Figure 2: Total cholesterol (mg/dL) for each intervention and overall group comparison versus Pre- (Time 
1) and 6 month (Time 2 or Post-) measurements.  Asterisk denotes statistical significance (p<0.05) between 
IEP vs. PBP scores. Standard error bars are on the overall scores exclusively. 
* 
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Table 4: The Time row demonstrates the overall TotChol main effect. Time * Treatment shows if there is 
significant TotChol interaction between groups (IEP or PBP +IEP). 
 
High-Density-Lipoprotein (HDL) 
There was a significant overall change observed between the participants‟ HDL values 
for the pre- and post- interventions, shown by figure 4 (Pre=54.6 ±15.5, Post=62.8 ±18.3 
mg/dL, p=0.005). Also, there was a significant within-group interaction, as shown in 
table 5 (p=0.038). 
Figure 4: High-density lipoprotein (mg/dL) for each intervention and overall group comparison versus Pre- 
(Time 1) and 6 month (Time 2 or Post-) measurements. Asterisk denotes statistical significance (p<0.05) 
between the overall group scores and IEP vs. PBP HDL scores. Standard error bars are on the overall 
scores exclusively.  
* 
* 
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Table 5: The Time row demonstrates the overall HDL main effect. Time * Treatment shows if there is 
significant HDL interaction between groups (IEP or PBP +IEP). 
 
Low-Density Lipoprotein 
A significant overall change was observed between the participants‟ LDL values for the 
pre- and post- interventions, shown by figure 5 (Pre=121.5 ±15.5, Post=104.2 ±18.3 
mg/dL, p=0.018). However, there was not a significant within-group interaction, as 
shown in table 5 (p=0.256). 
 
Figure 5: Low-density lipoprotein (mg/dL) for each intervention and overall group comparison versus Pre- 
(Time 1) and 6 month (Time 2 or Post-) measurements. Asterisk denotes statistical significance (p<0.05) 
the overall change in LDL. Standard error bars are on the overall scores exclusively. 
* 
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Table 6: The Time row demonstrates the overall LDL main effect. Time * Treatment shows if there is 
significant LDL interaction between groups (IEP or PBP +IEP). 
 
Resting Systolic Blood Pressure (SBP) 
There was a significant overall change observed between the participants‟ resting SBP 
values for the pre- and post- interventions, shown by figure 6 (Pre=126.7 ±9.7, 
Post=120.2 ±5.5 mmHg, p=0.020), but there was not a significant within-group 
interaction, as shown in table 7 (p=0.974). 
 
Figure 6: Resting SBP (mmHg) for each intervention and overall group comparison versus Pre- (Time 1) 
and 6 month (Time 2 or Post-) measurements. Asterisk denotes statistical significance (p<0.05) between the 
overall group scores. Standard error bars are on the overall scores only. 
* 
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Table 7: The Time row demonstrates the overall resting SBP main effect. Time * Treatment shows if there 
is significant resting SBP interaction between groups (IEP or PBP +IEP). 
 
Resting Heart Rate (HR) 
There was no significant overall change observed between the participants‟ resting HR 
values for the pre- and post- interventions, as shown by figure 7 (Pre=68.8 ±16.2, 
Post=68.2 ±10.8 beats min
-1
, p=0.977). Also, there were no within-group changes, as 
shown in table 8 (p=0.248). 
 
Figure 7: Resting heart rate (beats min
-1
) for each intervention and overall group comparison versus Pre- 
(Time 1) and 6 month (Time 2 or Post-) measurements. Interventions: IEP = individualized exercise 
prescription; PBP = pedometer-base program + IEP. Standard error bars are on the overall scores 
exclusively. 
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Table 8: The Time row demonstrates the overall main effect of resting HR. Time * Treatment shows if 
there is significant resting HR interaction between groups (IEP or PBP +IEP). 
 
Heart Rate at Stage 2 of Bruce Ramp treadmill protocol (HR@2) 
The overall observed change for HR@2 was not statistically significant between the 
participants‟ pre- and post- intervention values, shown by figure 8 (Pre=125.8 ±23.6, 
Post=123.2 ±18.5 beats∙min
-1
, p=0.358), nor was the within-group interaction, as shown 
in table 9 (p=0.431). 
 
Figure 8: Heart rate at stage 2 of treadmill protocol (beats min
-1
) for each intervention and overall group 
comparison versus Pre- (Time 1) and 6 month (Time 2 or Post-) measurements. Interventions: IEP = 
individualized exercise prescription; PBP = pedometer-base program + IEP. Standard error bars are on the 
overall scores only. 
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Table 9: The Time row demonstrates the overall main effect of heart rate at stage 2 of the Bruce Protocol. 
Time * Treatment shows if there is significant HR@2 interaction between groups (IEP or PBP +IEP). 
 
Rating of Perceived Exertion at Stage 2 of Bruce Ramp treadmill protocol (RPE@2) 
There was no significant overall change observed between the participants‟ RPE@2 
scores for the pre- and post- interventions, shown by figure 9 (Pre=11.6 ±1.8, Post=11.4 
±2.4, p=0.641), and there was no significant within-group interaction, as shown in table 
10 (p=0.941). 
 
Figure 9: Rating of perceived exertion at stage 2 of the Bruce Ramp treadmill protocol (BORG 6-20) for 
each intervention and overall group comparison versus Pre- (Time 1) and 6 month (Time 2 or Post-) 
measurements. Interventions: IEP = individualized exercise prescription; PBP = pedometer-base program + 
IEP. Standard error bars are on the overall scores exclusively. 
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Table 10: The Time row demonstrates the overall main effect of heart rate at stage 2 of the Bruce Protocol. 
Time * Treatment shows if there is significant HR@2 interaction between groups (IEP or PBP +IEP). 
 
Quality of Life (QOL) 
The RAND SF-36 survey measures eight different dimensions, which were each 
statistically analyzed according to the pre- and post- scores, and to the two different 
treatment groups (IEP or IEP+PBP). Role limitations due to physical health and 
emotional well-being statistically improved overall for both groups (p=0.04 and p=0.003, 
respectively), as shown in table 11. Also, the overall total quality of life statistically 
increased during the 6 month intervention, shown in figure 10 (p=0.039). The only 
interaction effects observed for quality of life were between the energy/fatigue scores 
(p=0.047), as shown in the appendix (A-3, pp70).  
 
Table 11: Descriptives for quality of life. *Denotes pre- post- intervention significance (p < 0.05). 
 
RAND SF-36 Dimensions Pre Mean±SD Post Mean±SD TTEST
Physical Functioning 84.4±26.9 90.6±19.6 0.117
*Role Limitations due to Physical Health 83.3±33.2 94.4±16.2 0.044
Role Limitations due to Emotional Problems 90.7±25.1 96.3±10.8 0.166
Energy/Fatigue 61.7±17.9 64.2±17.3 0.134
*Emotional Well-Being 78.4±14.5 81.8±13.5 0.003
Social Functioning 90.3±18.5 93.1±12.3 0.215
Pain 78.2±18.2 82.1±18.6 0.066
General Health 73.3±18.9 74.2±14.4 0.402
*Overall Total 640.4±134.1 676.6±90.8 0.039
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Figure 10: Quality of life (QOL) for each intervention and overall group comparison versus Pre- (Time 1) 
and 6 month (Time 2 or Post-) measurements. Interventions: IEP = individualized exercise prescription; 
PBP = pedometer-base program + IEP. Asterisk denotes statistical significance (p<0.05) between the 
overall group QOL scores. Standard error bars are on the overall scores exclusively. 
 
Cardiovascular Risk and Retention 
The average number of CVD risk factors for the initial 42 participants was 1.95 ±1.51, 
and the average number of CVD risk factors for the 19 participants that finished the study 
was 1.58 ±1.07. Those participants in the initial IEP group had 1.62 ±1.12 CVD risk 
factors, and those in the initial IEP+PBP group had 2.29 ±1.79 CVD risk factors. Of the 
participant population that consisted of the one-third at highest risk for CVD, 6 
participants completed the study, and 7 of the one-third at lowest risk for CVD completed 
the study. The average percent body fat (%BF) for 40 of the initial 42 participants was 
25.3 ±8.89, and the average %BF for 14 of the 19 participants that finished the study was 
27.0 ±9.79. There was no difference in study retention between those who were at highest 
risk vs. those at lowest risk prior to the study.  
* 
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CHAPTER V: DISCUSSION 
 
In the present study, we evaluated the efficacy of student-based exercise stress 
testing and CVD risk factor evaluation, coupled with two different exercise interventions 
that could reduce CVD risk and improve quality of life (QOL). The results of our study 
suggest that either of the two exercise interventions may decrease total cholesterol, 
increase high-density lipoproteins (HDL), decrease low-density lipoproteins (LDL), 
lower resting systolic blood pressure (SBP), and improve QOL. The current study did not 
produce significant changes in body mass index (BMI), fasted blood glucose (FBG), or 
exercising heart rate (HR) and rating of perceived exertion (RPE) at a fixed exercise 
workload (~6 METS).  
Similar exercise training studies have been shown to lower BMI, FBG, and 
increase exercise capacity. Hui et al. found that in 19 participants, the males decreased 
their BMI by 0.46 kg/m
2
 and the females lowered their BMI by 0.39 kg/m
2
,
 
after a 
walking intervention for 6 months. Also, Hui and colleagues found a 0.283 and 0.255 
mmol/L reduction in the men‟s and women‟s FBG, respectively, and they reported 
VO2max to increase with walking for 6 months, 5 days per week (45). Our overall pre- to 
post- measures for BMI and FBG did not significantly change as BMI slightly increased 
0.2 kg/m
2
 and FBG slightly increased 3.6 mg/dL.  
Unlike Hui and colleague‟s study, our study did not include dietary restrictions or 
recommendations. It is not uncommon for exercise only programs to actually increase or 
stabilize BMI while decreasing waist circumference, and/or decrease percent body fat 
while increasing lean body mass. Although body composition was measured pre- and 
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post-intervention in the current study, the data were not used as the measurement was 
administered differently by different students. Future evaluations in our lab should more 
carefully control the body composition measurement technique.    
A prospective cohort study of 38,987 women showed that 30 minutes of daily 
activity effectively reduced BMI and FBG (20).  Slentz and colleagues (2009) determined 
that an inactive control group experienced a significant increase in FBG and BMI in a 
study involving 387 sedentary, overweight adults assigned randomly to three different 
training groups and one control group (13).  
The lack of changes in BMI and FBG in the current study may have been 
attributed to a variety of variables. The exercise prescription and diet were not closely 
monitored throughout our study; thus, the energy expenditure might not have exceeded 
the energy intake significantly to reduce BMI or weight, which is closely related to 
changes in FBG. Also, FBG was often measured in the post-anthropometric testing, 
which may have resulted in higher than normal resting blood glucose values for some 
individuals. Future evaluations in our lab will address this issue.    
The blood lipid results from our study compliment prior studies that have shown 
that physical activity effectively increases HDL and decreases both LDL and total 
cholesterol. Leon and colleagues (2000) reported that 20 weeks (5 months) of supervised 
exercise significantly improved HDL by 3.6% (22). Our study showed a much larger 
15% overall increase in HDL for both groups. The increased HDL increase in the current 
study, may be attributed to: the daily exercise vs. 3 times per week in the Leon et al. 
study, to the self-selected exercise intensity in the current study, higher self-selected 
volume of exercise, or to a random effect of our smaller sample size, gender, or ethnicity 
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comparison differences. Larson-Meyer et al. (2010) studied an overweight population and 
found a 10% HDL increase and a 13% LDL decrease in their cohort, which included 
exercise and caloric reduction across a 6 month intervention (18). The HDL and LDL 
changes in the present study are more related to values observed for overweight 
individuals; however, the subjects in our study had a mean baseline BMI of 23.9 ±3.6, 
suggesting that improvements in lipoprotein metabolism, at least in the current study, 
were due to increased exercise, rather than weight reduction. 
Resting systolic blood pressure (SBP) decreased in our study, which is consistent 
with previous research. Blumenthal and colleagues (2000) found a 4 mmHg SBP 
reduction after an aerobic exercise intervention for 6 months in 133 sedentary and 
overweight men and women (10). Lifestyle interventions, which included increased 
physical activity, educational information, and dietary changes for 6 months were shown 
to decrease blood pressure and overall coronary heart disease risk in 810 relatively 
healthy adults (12).  
Hypertension is a common CVD risk factor, and our results suggest that both 
exercise prescription and exercise prescription with pedometer-base interventions 
effectively lowered overall resting SBP 6.5 mmHg (Figure 6), which is consistent with 
prior studies, although a number of 6 month exercise interventions have shown smaller or 
no improvements in SBP. It is possible that our study observed greater changes in resting 
SBP due to the pedometer daily log, as the participants were asked to report their steps 
each day, rather than only five days of the week. Therefore, the physical activity may 
have been increased in our study comparatively to other studies that only included five or 
fewer days per week of physical activity.  
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Heart rate (HR) during exercise and lower rating of perceived exertion (RPE) at 
the 2
nd
 stage of the Bruce treadmill protocol (~6 METS) did not change in the current 
study; however, overall averages were slightly lowered (HR decreased by 2.4 beats min
-1
 
and RPE decreased by 0.2 Borg units). The lack in change at about 6 METS may be due 
to the intensity, which is most likely a higher intensity than most of the participants chose 
for their self-selected exercise. Specificity of training suggests that improvements 
generally occur within the range of chronic exercise intensity. Haskell et al. (2007) 
reported that 150 minutes of moderately-intense exercise per week will promote 
physiological parameters of health, such as lower heart rate and increase physical activity 
levels (41). The current American College of Sports Medicine (ACSM) physical activity 
recommendations were promoted in both exercise prescription groups in our study, and 
favorable results of heart rate and physical activity may be due in part to the study‟s 
interventions. 
Previous studies have shown that exercise interventions can improve quality of 
life (QOL). We evaluated QOL in the current study with the RAND SF-36 health survey. 
Häkkinen and colleagues (2010) used the RAND SF-36 in a cross-sectional study on 727 
men and determined that health-related physical fitness promotes health-related QOL 
(26). A randomized controlled trial on 430 sedentary, postmenopausal women with 
elevated SBP suggested that 6 months of higher doses of exercise were associated with 
improvements in mental and physical aspects of QOL (23). The pre- and post- averages 
showed improvements in overall QOL amongst the whole group comparisons, and 
although our study did not show significant improvements in all areas, two of the 8 
dimensions, role limitations due to physical health and emotional well-being, showed 
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significant main effects for pre- and post- scores; whereas the energy/fatigue dimension 
was significantly improved in the individualized exercise prescription (IEP) group. 
The IEP group for our study was developed by undergraduate students to meet the 
following criteria: 1) The frequency, intensity, type, and duration of exercise was 
determined uniquely for each participant depending on results from a 12-lead ECG 
exercise stress test and anthropometric measures; 2) Each exercise program included a 
minimum of 2-4 days of resistance training and 3-5 days of aerobic training per week; 3) 
The exercise consisted of moderate to vigorous (3 to > 6 METS) intensity; and 4) The 
ACSM standards of 150 minutes of exercise per week were implemented (41). The 
participants in the pedometer-base program (PBP) received the IEP (above), plus a 
weekly phone call, and a daily step log that asked for the date, step goals, actual steps, 
general comments, and what was done for physical activity to be recorded (A-7, pp75).  
The major difference between the two groups was the compliance, with 73% of 
the PBP group completing the study vs. only 43% of the IEP group. The higher retention 
percent for the group in the PBP may be attributed to the daily pedometer log reporting, 
and/or a weekly phone call from the researcher (A-8, pp76). Both exercise programs 
seemed to be equally effective in reducing the CVD risk for those that completed the 
study, but the addition of the PBP greatly improved retention in the interventions.    
There were three major limitations to our study. 1) The sample size was relatively 
small and included mostly middle-aged Caucasians, limiting study power and population 
generalizability; 2) The participant retention was about 60% overall, and was unequal 
between the two groups, increasing the likelihood of unequal variance within groups; and 
3) Different researchers collected the data for the pre- and post- measurements. The 
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exercise data were collected by undergraduate students with limited experience in 
exercise blood pressure. Additionally, the test termination was often determined by 
inexperienced students and thus inconsistent. We believe the resting data, blood lipids, 
and blood glucose data to be accurate, but exercise blood pressure measurements, and the 
body composition data appear inconsistent and were not used in this analysis. 
The other limitations were medication changes and the absence of motivational 
strategies that encourage physical activity. Participation in the current study was 
voluntary with few physical and no monetary incentives to participate or complete the 
program. A number of participants were from out of town and did not perceive a benefit 
to complete the post testing, while others had schedule conflicts or simply chose not to 
complete the post-testing. Of the participants that did return, it was observed that at least 
two reported taking fewer medications.  
The motivation to exercise is not fully understood and often participant 
compliance may only occur after a life-threatening event. Therefore, until other 
motivation factors to maintain or increase physical activity are better understood, 
participant compliance may never reach 100% in training studies such as this or even in 
clinical settings, such as cardiac rehabilitation. Hagger and colleagues (2010) reported 
that a lack of self-control and self-regulatory skills are associated with low adherence to 
exercise (46). Training studies in the future might mitigate high participant dropout rates 
and low exercise motivation by implementing educational classes on self-regulation and 
self-control or practicing effective encouragement techniques to improve self-efficacy.      
In conclusion, the exercise prescription and pedometer-base interventions both 
reduced resting SBP and improved lipid profiles and QOL. There was no conclusive 
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evidence to support the hypothesis that adding the PBP to the IEP, further improved CVD 
risk factor reductions. However, the addition of the PBP and weekly phone calls may 
have improved the participant compliance. Compliance was related to being in the PBP 
vs. the IEP program and was not related to the number of baseline risk factors. Our study 
provides scientific evidence that the student-base exercise testing program at the 
University of Montana has a positive impact on CVD risk factors and quality of life. The 
stress testing program and the IEP, as performed by the HHP Exercise Science Students, 
was an effective program for practical learning and improving resting SBP, blood lipids, 
and QOL in middle-aged adults. 
Future research with training studies that involve exercise prescription and/or 
pedometers may help researchers understand the critical role exercise plays in reducing 
the risk factors associated with heart disease. Study designs evaluating exercise 
prescription and cardiovascular disease (CVD) risk factors may want to include a control 
group, resistance training group, and/or a pedometer-base only group. A motivational 
strategy that encourages exercise and self-regulation skills may want to be included in 
future studies to further mitigate CVD risk factors and improve quality of life. 
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Appendices 
A-1: Health Screening. 
PREPARTICIPATION HEALTH SCREENING QUESTIONNAIRE 
Evaluation and Prescription for Physical Activity in Adults with Chronic Disease 
 
The Human Performance Laboratory at The University of Montana – Health and Human Performance Dept. 
First Name Only:____________________________ Date of Birth__________ Today‟s 
Date__________ 
Address____________________________________ Phone (home)_____________ 
(work)______________ 
___________________________________________ Age________ Female______ 
Male_______ 
City State Zip 
ID #_____________Assigned by Lab 
Personnel   
Medical History and Risk Factors 
Have you had or been diagnosed with? 
(x) Start Date 
A heart attack or other heart trouble ( ) _______ 
High blood pressure ( ) _______ 
High cholesterol ( ) _______ 
Rheumatic fever ( ) _______ 
Artery disease or leg pain with exercise ( ) 
_______ 
Lung disease ( ) _______ 
Diabetes ( ) _______ 
Surgery ( ) _______ 
Injuries to back, knees, ankles, feet ( ) _______ 
Arthritis ( ) _______ 
Epilepsy ( ) _______ 
Drug Allergies ( ) _______ 
Explain_________________________________
______ 
_______________________________________
______ 
Have you recently had? (x) Date 
chest discomfort with exertion ( ) _______ 
leg pain with exercise ( ) _______ 
unreasonable breathlessness ( ) _______ 
dizziness, fainting, blackouts ( ) _______ 
Irregular heartbeats ( ) _______ 
Coughing with exertion ( ) _______ 
Back pain ( ) _______ 
Swollen, Stiff or Painful Joints ( ) _______ 
Fainting ( ) _______ 
Pregnancy ( ) _______ 
Family History Age Occurred Relationship 
Have any of your relatives had? 
Heart Attacks _______ ______________ 
_______ ______________ 
High Blood Pressure _______ ______________ 
_______ ______________ 
High Cholesterol _______ ______________ 
_______ ______________ 
Diabetes _______ ______________ 
_______ ______________ 
Congenital Heart Disease _______ 
______________ 
Other _______ ______________ 
Explain_________________________________
______ 
_______________________________________
______ 
------------------------------------------------------------------
------------- 
Please complete medication on the back 
side 
 
Smoking Yes No 
Do you smoke? ( ) ( ) 
Have you ever smoked? ( ) ( ) 
Cigarettes ( ) ( ) 
Pipe ( ) ( ) 
Cigar ( ) ( ) 
Smokeless tobacco ( ) ( ) 
If yes to any of the above, please indicate how 
many a day 
and for how many years. 
_______________________________________
_______ 
At what age did you start?______________ 
If you have stopped, 
when?_____________________ 
Why did you 
stop?______________________________ 
Nutrition 
Current Height ______feet ______inches 
Current weight_________lbs Weight 1 Year 
Ago?_______ 
Are you dieting?________ 
Why?____________________ 
_______________________________________
________ 
If dieting, what type of 
diet?_________________________ 
_______________________________________
________ 
Rate your diet in relation to fat content; e.g. 
butter, whole 
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milk, cheese, ice cream, chocolate, red meat, 
fried foods, 
baked goods: 
_________Low fat ________Average Fat 
_________Above average fat ________High fat 
Caffeine Intake______cups per day (Coffee, tea, 
cola, etc) 
Alcohol Intake_______drinks per week (wine, 
beer, liquor) 
(1 drink = 12 oz beer, 4 oz wine or 1.5 oz liquor) 
How often do you eat at fast food 
restaurants?_____week 
Do you eat processed foods (pre-prepared items 
such as 
cracker, frozen meals, boxed noodles) more than 
5 times a 
week ___yes __no 
Exercise 
Do you participate in regular physical 
activity?__________ 
Type of activity?______________(walk, run, 
swim, dance) 
Number of times per week?____________ 
Time and or distance per 
session?__________________ 
Is your occupation: 
_________Sedentary _________Mostly Inactive 
_________Active _________Heavy Work 
Any discomfort with moderate exercise not 
already noted? 
Explain_________________________________
________ 
_______________________________________
________ 
_______________________________________
________ 
Stress 
Rate yourself in relation to tension: 
________Usually relaxed 
________Relaxed, but occasionally tense 
________Tense more often than relaxed 
________Very tense 
Rate the amount of stress experienced in your 
occupation: 
________Little ________Average 
________Above average ________Severe 
 
Medications: Please complete as well as possible 
____ I am not regularly taking any medications. 
____ I regularly use the following medications. 
 
Medicine Name * This Medicine is for: How long have you been taking this medication? 
____________________ _________________________________ ___________________ 
____________________ _________________________________ ___________________ 
____________________ _________________________________ ___________________ 
____________________ _________________________________ ___________________ 
____________________ _________________________________ ___________________ 
____________________ _________________________________ ___________________ 
____________________ _________________________________ ___________________ 
____________________ _________________________________ ___________________ 
* If you do not remember the medication name please fill out the second column indicating the medication 
use. 
Health and Human Performance Dept., 101 McGill Hall, The University of Montana, Missoula, MT 59801 
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A-2: Informed Consent. 
 
SUBJECT INFORMATION AND INFORMED CONSENT 
Evaluation and Prescription for Physical Activity in Adults with Chronic Disease. 
PROJECT DIRECTOR: Steven Gaskill, Ph.D. 
CO‐DIRECTORS: Stephanie Domitrovich, MS, ATC, Bret Ralston, BS 
Health & Human Performance Dept. 
McGill Hall, Room 104 
Email: steven.gaskill@umontana.edu 
Phone: 406 243‐4268 
Special Instructions to the Potential Participant: 
This consent form may contain words that are new to you. If you read any words that are not clear to 
you, please ask the person who gave you this form to explain them to you. 
Purposes: 1) To evaluate physical fitness, chronic disease risk factors and the safety of exercise in 
individuals over 50 years old with or without known risk factors for heart and other chronic diseases or 
known chronic disease. 2) Provide exercise guidelines and prescription based on the fitness assessments 
and participant goals. 3) Provide practical clinical testing and exercise prescription for Health and Human 
Performance graduate and undergraduate students. 4) To determine the effectiveness of this program 
on reducing coronary heart disease risk factors. All testing is monitored by a trained faculty member. 
Procedures‐Overview: 
• Read this consent form. Ask any questions that you may have. If your questions are adequately 
answered and you feel that you fully understand what is expected and wish to participate in this 
project you will be asked to sign this consent form. 
• A student will contact you to schedule your testing. 
• This project will require 2‐4 visits to the Human Performance Laboratory for testing and 
evaluation along with an additional 1‐2 meeting with students at a location that works for you 
and the students. 
o The testing in the Human Performance Lab requires two hours and can be scheduled for 
one 2 hour visit or two 1 hour visits. All testing is done from 6:00‐8:00AM. The lab 
testing includes a treadmill stress test, flexibility evaluation, strength evaluation, a blood 
lipid and glucose measurement and body composition measurement. 
o The 1‐2 follow‐up visits with students are to discuss your results and develop a plan to 
reduce your risk factors (if any) for heart disease, diabetes or other chronic disease. 
• Half of the subjects will randomly be assigned to receive pedometers to track steps for the six 
months following the testing. Subjects will also complete a simple daily physical activity log and 
receive a weekly phone call to see how they are doing. The other half of the subjects will 
receive a monthly phone call to discuss program questions. 
• Subjects will complete the above tests a second time after 5 to 6 months. 
Procedures‐Specifics for each visit to the Human Performance Laboratory 
Along with the consent form you should have received a health screening form, an overview of the 
project and a map to the Human Performance Lab. A student will contact you to schedule your testing. 
All testing is done from 6:00‐8:00 AM in the Human. You have the option to schedule two separate one 
blocks on different days (6:00‐7:15AM or 6:45‐8:00AM) or one morning from 6:00 ‐ 8:00 AM. Please 
read this consent form and bring it with you to your first visit to the lab. Also please fill out and 
complete the health screening form and bring that with you to your first visit. 
Lab Testing: Requires about two hours. 
• Preparation: For the first visit we ask that you abstain from vigorous physical activity the day 
before your visit to the lab and that you do not eat after 10:00 PM the evening prior to the test. 
Please bring: 
o Appropriate exercise clothes and shoes for treadmill walking with the intensity varying 
from light up through moderately hard. 
o A swim suit for underwater weighing to determine body composition. 
� Men: Light shorts or a swim suit. 
� Women: T‐shirt and light shorts or a swim suit. 
o Risk Factor Screening Form: This comprehensive form is necessary for us to evaluate 
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your chronic disease risk factors and to evaluate the safety of performing an exercise 
test. This information, along with all other research data is confidential (see later note 
on confidentiality). 
o This consent form 
• Procedures: 
o Blood lipids/glucose evaluation: If you wish to have your blood glucose and lipid profile 
checked (blood triglycerides, total cholesterol, HDL cholesterol, LDL cholesterol) you 
should not eat after 10:00 PM the evening before your testing. If you do not wish the 
lipid evaluation, or have recently had your blood lipids checked, a three hour fast is 
adequate. 
• General measurements: We will measure body weight, height, waist and hip girth, resting heart 
rate and blood pressure. 
• Aerobic Stress Test: You will walk on the treadmill and participate in a graded exercise test 
starting at a comfortable walking speed with increasing in speed and grade (angle) every three 
minutes. We will increase your intensity only up to slightly above intensities that you normally 
do during daily living or physical activity. You will first have monitoring electrodes placed on 
your chest to monitor your heart (called an electrocardiograph or ECG). Your blood pressure will 
also be taken periodically during the testing. During the test you will periodically be asked to 
indicate how hard you are working (rate of perceived exertion (RPE) and if you have any chest 
pain. The testing will end at a moderately hard intensity or when you indicate that you have 
slightly exceeded the physical activity level that you normally do or that you would like to stop. 
The researchers may also decide to stop the test if we believe that it is in your best interest for 
safety or health. You can stop the test at any time by placing both hands on the side rails of the 
treadmill and straddling the belt. When the test has been ended, you will be allowed a cool 
down period continuing to walk on the treadmill at a slower pace without incline. This is a safe 
way of recovering from exercise. Monitoring of your ECG, heart rate and blood pressure will 
continue during the cool down period. For younger individuals with low risk for heart disease, 
you may choose to continue the test to your volitional maximal exertion. However, you may 
choose to stop at any time. 
• Flexibility: We will evaluate flexibility with two simple and safe flexibility tests that evaluate 
functional flexibility of the waist and hips (sit and reach test) and rotational flexibility of the 
torso (total body rotation test). We may do other flexibility tests as needed. 
• Body Composition: We measure body composition (% fat and % non‐fat) using the accepted 
underwater weighing standard. For this procedure you will be in our warm water tank and blow 
out as much air as possible while underwater and then hold your breath for about 3 seconds 
before surfacing. While not difficult it does take a few practice sessions to do this well. Please 
also bring a swim suit (women) or light shorts (men) for underwater weighing to determine 
body composition (risk factor for heart disease and diabetes). 
• Strength: We will complete strength measures including: a grip strength test using a hand grip 
measurement tool, and submaximal strength test of your legs (leg press) and of your upper body 
(bench press). Other simple and safe strength tests, such as the sit‐to‐stand test may be 
administered as necessary to evaluate upper and lower body strength. 
• Quality of Life Survey: You will fill out a survey containing 36 questions to determine mood state 
and quality of life. 
 Exercise Results Visits: These visits will require about 1 hour for 2 visits. 
If you wish to meet with a student to go over your data and have them recommend physical 
activity and lifestyle changes to reduce your future risk of chronic disease you will be given that 
opportunity to schedule an appointment. The meetings can take place at a location convenient 
for both you and the student. The first visit is generally to go over your results and to discuss 
goals and a possible program with the student. The student may also show you how to do safe 
resistance training exercises. If you wish to schedule a second meeting with the student to go 
over the plan that they develop, based on your first meeting, the student will be happy to meet 
with you once more. If you would prefer, the student can sent or deliver the program they 
develop. 
You may also receive periodic phone calls (not more than one a week) to check up and see how 
you are doing, to answer any questions you may have for us, or to help you in adjusting to your 
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program. 
This service is offered every term on a first come, first served basis until our appointment schedule is 
filled. If you would like to repeat the testing the following academic semester or following year please 
contact Dr. Gaskill (406‐243‐4268 or steven.gaskill@umontana.edu). Retesting will help you evaluate 
the success of your lifestyle changes to reduce your risk of heart disease, diabetes and other chronic 
diseases. 
 
Payment or Cost for Participation: 
There is no cost for this service as a part of the HHP 483/484 (Exercise, Aging and Chronic Disease) class 
for the lipid and blood glucose panel or strength, flexibility, stress test and body composition testing. 
You will not receive any compensation for your participation in this study. You will however, be provided 
with information on your muscular, aerobic and flexibility fitness as well as consultation(s) to develop an 
appropriate and safe physical activity program. 
Risk/Discomforts: 
Physical activity often includes some risks; however risks in this project are minimal. You will be asked to 
report known risk factors for heart disease (age, family history of heart disease, smoking history, 
physical activity history, hypertension and known diabetes), current medications and recent or current 
illnesses. We will measure blood pressure and monitor your ECG to evaluate the safety of moderate 
intensity physical activity. You will be asked to perform a walking exercise test which has a possibility of 
causing muscle soreness or strain and may cause shortness of breath. There is the slight potential for 
myocardial ischemia, angina or coronary arrhythmias during the testing, especially for older individuals 
and for those with multiple risk factors. All guidelines of the AMA and American College of Sports 
Medicine for exercise testing guidelines are being followed and risk should be minimal. In the event that 
you feel pain or discomfort during the walking test, which you feel is not normal, you must notify the 
researchers. You can choose to withdraw from the project at any time. 
Benefits: 
By participating in this study, you will obtain information on your level of fitness, an assessment of 
cardiovascular disease risk factors and analysis of your body composition. All of your individual results 
will be made available to you and questions will be answered. Finally, students in the Health and 
Human Performance Dept. under supervision of faculty members will work with you to develop a 
comprehensive physical activity and behavior modification plan to reduce your risk from chronic 
disease. 
Confidentiality: 
� Your records will be kept private and will not be released without your consent except as required 
by law. 
� Only the faculty advisor and the students working directly with you will have access to your files. 
� Your identification will be kept confidential. Once your testing is completed and consultations are 
completed we will give you all copies of your data. We assign you a subject number and keep a 
record of your data identified only by subject number. A separate list name and subject number is 
kept in a separate locked location. 
� If the data are used for publication, case studies, presentations or teaching purposes, no names will 
be used. 
� Your signed consent form will be stored in a secure location separate from your data. 
Compensation for Injury: 
Although we believe that the risk of taking part in this study is minimal, the following liability statement is 
required in all University of Montana consent forms. 
“In the event that you are injured as a result of this research, you should individually seek appropriate 
medical treatment. If the injury is caused by the negligence of the University or any of its employees, you 
may be entitled to reimbursement or compensation pursuant to the Comprehensive State Insurance Plan 
established by the Department of Administration under the authority of M.C.A., Title 2, Chapter 9. In the 
event of a claim for such injury, further information may be obtained from the University’s Claims 
Representative or University Legal Council”. (Reviewed by University Legal Counsel, July 6, 1993) 
Voluntary Participation /Withdrawal: 
• Your decision to take part in this project is entirely voluntary. You may refuse to take part or 
withdraw from the project at any time without penalty or loss of benefits to which you are 
normally entitled. Choosing to participate, or to withdraw, will have no bearing on my status 
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with any program or association at The University of Montana. You may leave the study for any 
reason. 
• You may be asked to leave the study for any of the following reasons: 
o Failure to follow the Project Director‟s instructions; 
 
Disclosure of Personal Health Information 
My individual health information that may be used to conduct this research includes: 
Blood lipid and glucose data, electrocardiograms, body composition data, medical 
history, health history and fitness data. 
I authorize Steven Gaskill, Ph.D. and the researcher‟s staff to use my individual health 
information for the purpose of conducting the research project entitled “Evaluation and 
Prescription for Physical Activity in Adults with Chronic Disease.” 
Signature: ___________________________________ Date: ____________________ 
 
o A serious adverse reaction which may require evaluation; 
o The Project Director thinks it is in the best interest of your health and welfare; or 
o The study is terminated. 
Questions: 
If you have any questions about the research now or during the study contact: 
• Steven Gaskill, Ph.D. in McGill Hall at 243‐4268 
email: steven.gaskill@umontana.edu 
If you have any questions regarding your rights as a research subject, you may contact the Institutional 
Review Board Chair through the Research Office at the University of Montana at 243‐6670. 
 
Subject’s Statement of Consent: 
Evaluation and Prescription for Physical Activity in Adults with Chronic Disease. 
I have read the above description of this research study. I have been informed of the risks and benefits 
involved, and all of my questions have been answered to my satisfaction. Furthermore, I have been assured 
that a member of the project team will also answer any future questions I may have. I voluntarily agree to 
take part in this study. I understand I will receive a copy of this consent form. 
Printed Name of Subject: ______________________________________________ 
Subject‟s Signature: _____________________________ Date: ___________ 
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A-3: SPSS® Tables and Figures  
 
Body Mass Index 
   
  
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Fasted Blood Glucose 
 
   
 
  
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Total Cholesterol 
 
   
 
  
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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High-Density Lipoprotein 
 
   
  
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Low-Density Lipoprotein 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Resting Systolic Blood Pressure 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Resting Heart Rate 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Heart Rate at Stage 2 of Bruce Protocol 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Rating of Perceived Exertion at Stage 2 of Bruce Protocol 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life 
 
 
 
Basic Descriptives. N=18. mean±SD. EPcontrol = Individualized Exercise Prescription (Group 1) 
EPPBex = Individualized Exercise Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – Physical Functioning 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – Role Limitations due to Physical Health 
 
   
   
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – Role Limitations due to Emotional Problems 
 
   
   
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – Energy/Fatigue 
 
   
   
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – Emotional Well-Being 
 
   
   
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – Social Functioning 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – Pain 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – General Health 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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Quality of Life – Overall 
 
   
  
 
 
 
*EPcontrol = Individualized Exercise Prescription (Group 1) & EPPBex = Individualized Exercise 
Prescription and Pedometer-Base Program (Group 2) 
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A-4: Recruitment Brochure. 
 
 
 
 
 
Exercise 
Stress- 
Testing 
Program 
We started this as a cooperative 
program between the Health and 
Human Performance (HHP) Dept. at 
the University of Montana and the 
American Heart Association – Missoula 
Go Red program – and over the past 
several years have expanded to 
include University on Montana 
Employees and retirees who are 50 
years or older or who have multiple risk 
factors for CHD or metabolic syndrome 
(ie: high blood pressure, high 
cholesterol, overweight, physically 
inactive, high blood sugar, shortness of 
breath during light exercise, etc.).  
The service includes health 
screening, a finger prick blood analysis 
of glucose and cholesterol, a treadmill 
stress test, basic strength and flexibility 
testing and body composition analysis.  
A results packet is put together by HHP 
students specific to your results.  A 
team of students will meet with you to 
go over your results and help you 
develop a plan to reduce your risk 
factors for chronic diseases and to help 
you become more physically active.  
This is a free service by HHP 
students and faculty for University 
faculty, staff and Missoula Community 
members.  Males and females are 
invited to participate.  You can 
participate even if you have known 
heart disease, diabetes, hypertension 
or other ailments!  We adjust the 
intensity of the exercise test to your 
degree of risk and adhere to exercise 
testing and prescription guidelines of 
the American College of Sports 
Medicine and AMA. 
Purpose: 
1) Provide on-going testing (stress, 
aerobic, strength, body 
composition and risk factor) and 
behavior change consultations 
for University faculty, staff and 
Missoula Community members. 
2) Help University faculty, staff and 
Missoula Community members 
understand their risk factors for 
heart disease and other chronic 
diseases and how to change 
lifestyle behaviors to improve 
health. 
3) Provide hands-on learning for 
senior students in the HHP 
department.  These are great 
students and you provide a 
wonderful resource for them to 
learn how to work with clients.  
All student stress testing is 
supervised by Dr. Gaskill.  The 
students are learning and we 
ask that you help them by giving 
positive feedback or suggestions 
to improve as necessary. 
 
 
 
Program: 
1) Testing is completed in April and 
May during the spring semester 
plus October and November 
during the fall semester. 
2) You can chose which aspects of 
the program you would like to 
participate in, but we encourage 
all tests. 
3) The stress testing intensity is 
limited by the numbers of risk 
factors that you have, or if you 
have known heart disease.  
Thus, the stress test may only 
be administered through 
moderate intensity, but if 
allowed, you may be pushed to 
a moderately hard intensity.  
Since we do not take most 
participants to maximal intensity, 
the stress test cannot rule out 
heart disease, but can give you 
feedback on the safety of 
exercise at moderate to 
moderately hard intensities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Getting started: 
If you are interested, please email 
Steven Gaskill, Ph.D. at the University 
of Montana with your email address 
and phone number where we can 
contact you.  You will be emailed a 
packet of information and can decide if 
you want to participate.  We would love 
to have you. 
Steven.gaskill@umontana.edu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Beginning: 
October 2010 
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A-5: Bruce Ramp Protocol. 
Stage MPH Grade HR RPE Angina BP ECG Notes 
Resting        
Standing        
Warm-up 2.0 0      
Bruce 1 1.8 10      
Bruce 2 2.5 12      
Bruce 3 3.4 14      
Bruce 4 4.2 16      
Recovery 2.0 0      
Seated        
 
A-6: ACSM Guidelines for Terminating a Stress-Test. 
 
 
1. Onset of Angina or angina-like symptoms 
2. Ventricular tachycardia 
3. Significant decrease in SBP, 20 mmHg or more 
4. Failure of SBP and/or HR to rise with an increase in exercise load 
5. Light-headedness, confusion, ataxia, pallor, cyanosis, nausea, or signs of 
severe peripheral circulatory insufficiency. 
6. Early onset horizontal or down sloping S-T segment depression or elevation 
(>4mm) 
7. Increasing ventricular ectopy, multiform PVCs 
8. Excessive increase in blood pressure: systolic>260mmHg; diastolic>115mmHg 
9. Decrease in HR < 25 beats∙min
-1
 of predicted normal value (in the absence of 
beta blockade medicine) 
10. Sustained supraventricular tachycardia  
11. Subject requests to stop test for whatever reason 
12. Equipment failure 
From: ACSM’s Guidelines for Exercise Testing and Prescription. 8
th
 Ed. Baltimore: 
Lippincott, Williams & Wilkins, 2009. 
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A-7: Pedometer Log. 
 
                 Weekly Recording Log
Client ID #:_______________________________________________
Date Step Goal Actual Steps General Comments
INSTRUCTIONS
For each day:
       • You can record the date under the "Date" box
       • Record a personal step goal based on your plan or goals (The American
          College of Sports Medicine recommends 10,000 steps per day for health)
       • Before bed, record the number of steps your pedometer reads for the day
       • Under "General Comments" above, note the duration of your activity/exercise  
           and a description of the type of activity/exercise
       * Please remember, we hope that you can record your steps each day, 
          but we do understand when some days are missed.
What You Did For Physical Activity
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A-8: Weekly Call Log for Pedometer-Base Group. 
 
 
12/10/2010 Client ID No Contact Contact Left Message 12/17/2010 Client ID No Contact Contact Left Message 1/14/2011 Client ID No Contact Contact Left Message
1 x 1 x 1 x
3 x 3 x 3 x
5 x 5 x 5 x
8 x 8 x 8 x
9 x 9 x 9 x
14 x 14 x 14 x
15 x 15 x 15 x
17 x 17 x 17 x
18 x 18 x 18 x
19 x 19 x 19 x
20 x 20 x 20 x
25 x 25 x 25 x
26 x 26 x 26 x
28 x 28 x 28 x
32 x 32 x 32 x
33 x 33 x 33 x
34 x 34 x 34 x
35 x 35 35 x
38 x 38 x 38 x
39 x 39 x 39 x
40 x 40 x 40 x
1/21/2011 Client ID No Contact Contact Left Message 1/29/2011 Client ID No Contact Contact Left Message 2/3/2011 Client ID No Contact Contact Left Message
1 x 1 x 1 x
3 x 3 x 3 x
5 x 5 x 5 x
8 x 8 x 8 x
9 x 9 x 9 x
14 x 14 x 14 x
15 x 15 x 15 x
17 x 17 x 17 x
18 x 18 x 18 x
19 19 x 19 x
20 x 20 x 20 x
25 x 25 x 25 x
26 x 26 x 26 x
28 x 28 x 28 x
32 x 32 x 32 x
33 x 33 x 33
34 x 34 x 34 x
35 x 35 x 35 x
38 x 38 x 38 x
39 x 39 x 39 x
40 x 40 x 40 x
2/10/2011 Client ID No Contact Contact Left Message 2/18/2011 Client ID No Contact Contact Left Message
1 x 1 x
3 x 3 x
5 x 5 x
8 x 8 x
9 x 9 x
14 x 14 x
15 x 15 x
17 x 17 x
18 x 18 x
19 x 19 x
20 x 20 x
25 x 25 x
26 x 26 x
28 x 28 x
32 x 32 x
33 x 33 x
34 x 34 x
35 x 35 x
38 x 38 x
39 x 39 x
40 x 40 x
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A-9: RAND SF-36 – Quality of Life Survey
 
78 
 
 
 
